Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
01/03/1996 | EP0690129A1 Novel entities for cancer therapy |
01/03/1996 | EP0690127A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
01/03/1996 | EP0690126A1 Novel proteins with factor VIII activitiy: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them |
01/03/1996 | EP0689843A1 Composition containing soluble thrombomodulins |
01/03/1996 | EP0689606A1 ANTIBODIES AND ASSAYS FOR DETERMINING MUTATIONS IN THE $i(APC) GENE |
01/03/1996 | EP0689604A1 Process for preparing cancer vaccines |
01/03/1996 | EP0689603A1 Defective mutant non-retroviral virus (e.g. hsv) as vaccine |
01/03/1996 | EP0689602A1 Delivery system controlled through factors associated with hiv and cell |
01/03/1996 | EP0689600A1 Process to induce the death of tumor cells |
01/03/1996 | EP0689599A1 Chimeric selectin by exchange of domains - uses thereof |
01/03/1996 | EP0689596A1 Stimulation of immune response by viral protein |
01/03/1996 | EP0689595A1 Plant promoter, microorganisms and plant cells containing a unit for the expression of a protein of interest comprising said promoter |
01/03/1996 | EP0689594A1 Dna, dna constructs, cells and plants derived therefrom |
01/03/1996 | EP0689593A1 Inhibition of selected tumor growth with recombinant viral sector |
01/03/1996 | EP0689592A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
01/03/1996 | EP0689591A1 Testing for infestation of rapeseed and other cruciferae by the fungus leptosphaeria maculans (blackleg infestation) |
01/03/1996 | EP0689590A1 Totally synthetic affinity reagents |
01/03/1996 | EP0689588A1 Extracellular signal-regulated kinase, sequences, and methods of production and use |
01/03/1996 | EP0689586A1 Vpr function and activity |
01/03/1996 | EP0689552A1 A method of detecting rupture of the amniotic membranes in pregant mammals |
01/03/1996 | EP0689551A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
01/03/1996 | EP0689550A1 Novel antimicrobial peptides from bovine neutrophils |
01/03/1996 | EP0689548A1 Human serotonin receptors, dna encoding the receptors, and uses thereof |
01/03/1996 | EP0689547A1 Cloned human alpha1c adrenergic receptor |
01/03/1996 | EP0689459A1 Novel agent for controlling cell activity |
01/03/1996 | EP0689453A1 High molecular weight surface proteins of non-typeable haemophilus |
01/03/1996 | EP0689451A1 Pharmaceutical compositions comprising a ligand complexed with a soluble receptor |
01/03/1996 | EP0689450A1 Potassium channel blocking compounds and their use |
01/03/1996 | EP0689448A1 Angiogenine, and/or alpha1-microglobuline and/or complementary factor d for limiting protein secretion |
01/03/1996 | EP0689421A1 Reduced and controlled surface binding of biologically active molecules |
01/03/1996 | EP0498851B1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
01/03/1996 | EP0478602B1 Expression of tetanus toxin fragment c |
01/03/1996 | EP0473701B1 Recombinant dna method for production of parathyroid hormone |
01/03/1996 | EP0444158B1 Conjugated polypeptides and methods for their preparation and use |
01/03/1996 | EP0440686B1 Peptides representing epitopic sites on r-ifn-beta, antibodies thereto, and uses thereof |
01/03/1996 | EP0317622B1 Prevention and treatment of retroviral disease |
01/03/1996 | EP0316440B1 System and method for providing localized Mössbauer absorption in an organic medium |
01/03/1996 | EP0275300B1 Recombinant vaccine |
01/03/1996 | CN1114358A Isolation, quantitation and purification of insecticidal proteins from endotoxins of bacillus thuringiensis |
01/03/1996 | CN1114322A Process for preparing growth factor of human nerve by embryonic down or decidual |
01/02/1996 | US5481021 Phenyl amidines derivatives useful as platelet aggregation inhibitors |
01/02/1996 | US5480981 Hodgkin's disease |
01/02/1996 | US5480974 Blocking agents, antiinflammatory |
01/02/1996 | US5480972 Diagnosing, treating and preventing sensitivity; dna sequences |
01/02/1996 | US5480968 Isolated polypeptide erbB-3, related to the epidermal growth factor receptor and antibody thereto |
01/02/1996 | US5480967 HIV-1 core protein fragments |
01/02/1996 | US5480966 Peptides derived from the envelope glycoprotein of HIV viruses, their applications to the detection of infection caused by these viruses and to the vaccination against AIDS |
01/02/1996 | US5480956 Feline interferon and process for production thereof |
01/02/1996 | US5480895 Method of producing antibodies to a restricted population of T lymphocytes, antibodies produced therefrom and methods of use thereof |
01/02/1996 | US5480870 Heptapeptide and octapeptide amide derivatives; treatment of excessive secretion of insulin, glucagon or growth hormone |
01/02/1996 | US5480869 Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues |
01/02/1996 | US5480867 Glucagon analogs with serine replacements |
01/02/1996 | US5480864 Modified maxadilan fusion protein containing a thrombin cleavage site; composition for topical application to mammals' skin comprises modified maxadilan protein as vasodilator in vehicle |
01/02/1996 | US5480825 AG-F human T cell line with unique phenotype and cytokine secretions |
01/02/1996 | US5480801 Purified PH neutral Rhizoctonia laccases and nucleic acids encoding same |
01/02/1996 | US5480799 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
01/02/1996 | US5480797 Augmenter of liver regeneration (ALR) |
01/02/1996 | US5480796 Antibodies against the receptor protein for human B cell stimulatory factor-2 |
01/02/1996 | US5480795 Curculin B and DNA encoding same, and process for production thereof |
01/02/1996 | US5480790 Water-soluble proteins modified by saccharides |
01/02/1996 | US5480782 Process for obtaining cellular protein having anti-HIV activity |
01/02/1996 | US5480378 Apparatus for preparing a concentrate of coagulation factors from a blood sample |
01/02/1996 | CA2150532A1 Polypeptides |
01/02/1996 | CA1337891C Anf derivatives with novel bridging |
01/02/1996 | CA1337861C De-acyl derivatives of antibiotic a 40926 |
01/02/1996 | CA1337859C Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine |
12/28/1995 | WO1995035501A1 Cell calcium regulation and its use |
12/28/1995 | WO1995035387A1 Regulated expression of heterologous genes in plants and transgenic fruit with a modified ripening phenotype |
12/28/1995 | WO1995035386A1 Expression control polynucleotides derived from spliceosomal protein gene promoters |
12/28/1995 | WO1995035384A1 N-terminally extended proteins expressed in yeast |
12/28/1995 | WO1995035380A1 Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
12/28/1995 | WO1995035379A1 66 kDa ANTIGEN FROM BORRELIA |
12/28/1995 | WO1995035378A1 Novel bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
12/28/1995 | WO1995035376A2 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains |
12/28/1995 | WO1995035374A1 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
12/28/1995 | WO1995035373A2 Nucleic acid molecules encoding human contactin |
12/28/1995 | WO1995035372A1 5-lipoxygenase-activating protein ii |
12/28/1995 | WO1995035371A1 Glucan elicitor receptor and dna coding for the same |
12/28/1995 | WO1995035370A1 Schistosoma protein and uses thereof |
12/28/1995 | WO1995035368A1 Extraction of heterologous insoluble proteins from bacteria |
12/28/1995 | WO1995035366A1 Animal model for alzheimer's disease |
12/28/1995 | WO1995035320A1 High-affinity melatonin receptors and uses thereof |
12/28/1995 | WO1995035319A1 Ctcf |
12/28/1995 | WO1995035318A1 Plant genes for sensitivity to ethylene and pathogens |
12/28/1995 | WO1995035317A1 Identification, quantitation and purification of insecticidal proteins from bacillus thuringiensis |
12/28/1995 | WO1995035306A1 Process for separating alpha1-proteinase inhibitor from cohn fraction iv1 and iv4 paste |
12/28/1995 | WO1995035119A1 METHODS AND COMPOSITIONS INCLUDING A 13 kD B. BURGDORFERI PROTEIN |
12/28/1995 | WO1995035118A1 Contraceptive vaccine |
12/28/1995 | WO1995035116A1 Hgh containing pharmaceutical compositions |
12/28/1995 | WO1995035115A1 DNA ENCODING AN 18 Kd CDK6 INHIBITING PROTEIN |
12/28/1995 | WO1995035114A1 Borrelia burgdorferi exported plasmid protein a, nucleic acids encoding thereof, and uses thereof |
12/28/1995 | WO1995035024A1 Plant virus resistance gene and methods |
12/28/1995 | WO1995033818A3 Genes for the synthesis of antipathogenic substances |
12/28/1995 | WO1995032286A3 Immunogenic carcinoembryonic antigen and methods of use and production |
12/28/1995 | WO1995028487A3 Recombinant pgp3, methods of preparation and use in diagnosis and therapy |
12/28/1995 | WO1995027495A3 Treatment of partial growth hormone insensitivity syndrome |
12/28/1995 | WO1995020664A3 Mammalian expression systems for hepatitis c virus envelope genes |
12/28/1995 | WO1995017512A3 Proteases from streptomyces and use thereof in protein expression systems |
12/28/1995 | WO1995016051A3 Methods and compositions for the suppression of neu mediated transformation |
12/28/1995 | WO1995014713A3 Abundant extracellular products and methods for their production and use |